This inventor holds 10 USPTO granted patents and 14 published patent applications, plus 7 CIPO patents and 6 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (2013)
- Tokushima-ken, JP (2015 - 2017)
- Osaka, JP (2015 - 2023)
Company Filing History:
Years Active: 2013-2023
Title: Shogo Hiraoka: Innovator in Medical Device Technology
Introduction
Shogo Hiraoka is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical devices, particularly through his innovative work involving aripiprazole formulations. With a total of 10 patents to his name, Hiraoka continues to push the boundaries of medical technology.
Latest Patents
Hiraoka's latest patents include a medical device containing a cake composition comprising aripiprazole as an active ingredient. This invention aims to suppress the agglomeration of aripiprazole in a suspension obtained by resuspending a freeze-dried substance. Additionally, he has developed a freeze-dried aripiprazole formulation that exhibits good dispersibility, allowing for easy reconstitution into a homogenous suspension when mixed with water.
Career Highlights
Shogo Hiraoka is currently employed at Otsuka Pharmaceutical Company, Limited, where he applies his expertise in pharmaceutical innovations. His work focuses on enhancing the effectiveness and usability of medical devices, particularly those involving complex formulations.
Collaborations
Hiraoka collaborates with notable colleagues such as Takakuni Matsuda and Akifumi Takeuchi. Together, they contribute to advancements in medical technology and the development of innovative solutions in the pharmaceutical industry.
Conclusion
Shogo Hiraoka's contributions to medical device technology highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to shape the future of pharmaceutical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
